Treatment and Dosimetric Advantages Between VMAT, IMRT, and Helical TomoTherapy in Prostate Cancer
- 15 July 2010
- journal article
- Published by Elsevier BV in Medical Dosimetry
- Vol. 36 (3), 264-271
- https://doi.org/10.1016/j.meddos.2010.05.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- An approach to multiobjective optimization of rotational therapyMedical Physics, 2009
- RapidArc volumetric modulated therapy planning for prostate cancer patientsActa Oncologica, 2009
- Intensity-Modulated Radiation Therapy: Supportive Data for Prostate CancerSeminars in Radiation Oncology, 2008
- Volumetric modulated arc therapy: IMRT in a single gantry arcMedical Physics, 2007
- Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialThe Lancet Oncology, 2007
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the ProstateJAMA, 2005
- Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2002
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancerRadiotherapy and Oncology, 2000